Showing 6,261 - 6,280 results of 31,940 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((fold decrease) OR (nn decrease)) ))', query time: 0.56s Refine Results
  1. 6261

    Bar graph showing proportion of NADCs. by Raymond Atwine (18574812)

    Published 2025
    “…The Commonest ADC was Kaposi Sarcoma (KS) while the commonest NADC was Squamous cell carcinoma, Not otherwise specified. Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”
  2. 6262

    Baseline characteristics of study participants. by Raymond Atwine (18574812)

    Published 2025
    “…The Commonest ADC was Kaposi Sarcoma (KS) while the commonest NADC was Squamous cell carcinoma, Not otherwise specified. Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”
  3. 6263

    S1 Data - by Shane R. McClafferty (19434460)

    Published 2024
    “…Once pups had reached adolescence (PND 50), researchers tested for differences in anxiety, activity, and social behavior using elevated plus-maze, open field habituation, a three-chamber social interaction, and a social discrimination task. …”
  4. 6264
  5. 6265
  6. 6266
  7. 6267
  8. 6268

    S4 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  9. 6269

    S6 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  10. 6270

    S3 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  11. 6271

    S9 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  12. 6272

    S7 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  13. 6273

    S1 Raw data - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  14. 6274

    S8 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  15. 6275

    S2 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  16. 6276

    S1 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  17. 6277

    S5 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  18. 6278
  19. 6279
  20. 6280